Hypercholesterolemia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was to investigate the effects of HS and GP tea consumption on anthropometric data, fasting blood glucose (FBG), and lipid concentrations in hypercholesterolemia subjects with different genotypes of the APOE and CETP TaqIB polymorphisms.
|
28244718 |
2017 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
APOE-e4 associated with a higher likelihood of hypercholesterolemia and overall illness index scores (ps < .05).
|
27486898 |
2016 |
Hypercholesterolemia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Here, we test whether hypercholesterolemia (HC) and ApoE polymorphisms affect the risk of ICH by statin use.
|
24008570 |
2013 |
Hypercholesterolemia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We analyzed whether low birth weight and apolipoprotein E (Apo E) polymorphism participate in the onset of hypercholesterolemia in children.
|
18052682 |
2008 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Other murine models target genes relevant to AMD, including inflammatory genes such as Cfh(-/-), Ccl2(-/-), Ccr2(-/-), Cx3cr1(-/-), and Ccl2(-/-)/cx3cr1(-/-), oxidative stress associated genes such as Sod1(-/-) and Sod2 knockdown, metabolic pathway genes such as neprilysin(-/-) (amyloid beta), transgenic mcd/mcd (cathepsin D), Cp(-/-)/Heph(-/Y) (ferroxidase ceruloplasmin/hepaestin, iron metabolism), and transgenic ApoE4 on high fat and high cholesterol diet (lipid metabolism).
|
20206286 |
2010 |
Hypercholesterolemia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
APOE ε4 allele is an established risk factor for Alzheimer's disease and hypercholesterolemia.
|
31677348 |
2019 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Therefore, the effects of diet-induced hypercholesterolemia on cardiac function and remodeling were investigated up to eight weeks after myocardial ischemia-reperfusion (MI-R) injury which was induced in either normocholesterolemic (NC-MI) or hypercholesterolemic (HC-MI) APOE*3-Leiden mice.
|
31199833 |
2019 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Apolipoprotein-E/galectin-3 knockout mice were generated and fed a high-cholesterol "western" diet.
|
23426722 |
2013 |
Hypercholesterolemia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Hypercholesterolemia with statin use was associated with less risk of ICH (OR=0.30; P=0.0008) in multivariable analysis after controlling for alcohol use, hypertension, previous stroke, first-degree relative with ICH, education level, and apolipoprotein E alleles.
|
15087556 |
2004 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
We investigated the effect of perinatal hypercholesterolemia on the atherosclerosis development in the offspring of apolipoprotein E-deficient mice and the underlying mechanism.
|
28935756 |
2017 |
Hypercholesterolemia
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Gestational hypercholesterolemia alters fetal hepatic lipid metabolism and microRNA expression in Apo-E-deficient mice.
|
31453710 |
2019 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
HPO |
|
|
|
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
RESULTS APOE was significantly associated with hypercholesterolaemia (epsilon4 72% vs. epsilon3 66% vs. epsilon2 51%; P < 0.0001), and premature MI (epsilon4 57% vs. epsilon3 50% vs. epsilon2 41%; P < 0.0001; hazard ratio 1.41, 95%CI 1.14-1.75).
|
17217375 |
2007 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
CTD_human |
Antiatherogenic effect of bisvanillyl-hydralazone, a new hydralazine derivative with antioxidant, carbonyl scavenger, and antiapoptotic properties.
|
21043830 |
2011 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
In addition to our previous finding, this study indicates that hypercholesterolemia in apoE4-carrying NIDDM patients may be more closely related to poor metabolic control and increased percentage of ideal body weight.
|
2060414 |
1991 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
We established a novel atherosclerosis-susceptible mouse model with both severe HHcy and hypercholesterolemia in which the mouse cystathionine beta-synthase (CBS) and apolipoprotein E (apoE) genes are deficient and an inducible human CBS transgene is introduced to circumvent the neonatal lethality of the CBS deficiency (Tg-hCBS apoE(-/-) Cbs(-/-) mice).
|
19858416 |
2009 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
RGD |
We used apolipoprotein E gene knockout (ApoE KO) rats to induce hypercholesterolemia through a special high cholesterol/bile salt diet (Paigen diet), then analyzed aortic and coronary atherosclerosis lesions and the myocardial injury in order to establish a novel small animal model of coronary atherosclerosis.
|
28808185 |
2016 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
So far the major findings have included: apolipoprotein E e4, a major risk factor for AD in most populations, is also a risk factor for AD in African Americans but not for Yoruba; African Americans are at higher risk not only for AD, but also for diseases associated with increased cardiovascular risk such as hypertension, diabetes, and metabolic syndrome; African Americans have higher rates of hypercholesterolemia than Yoruba: there is an interaction between apolipoprotein E e4, cholesterol, and AD risk in both Yoruba and African Americans.
|
16917194 |
2006 |
Hypercholesterolemia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
To examine a long-term effect of community-based education program for hypercholesterolemia and an effect modification by apolipoprotein E polymorphism, we conducted a 1-year randomized clinical trial with 8 year-follow-up.
|
12119210 |
2002 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
The relation of hypercholesterolemia and apolipoprotein E (ApoE) to cerebral aneurysm formation, has been unclear until now.
|
18360691 |
2008 |
Hypercholesterolemia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
APOE genotypes were not associated with hypercholesterolemia.
|
30457419 |
2019 |
Hypercholesterolemia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The interaction effect between APOE genotype and hypercholesterolemia was statistically significant in both cohorts.
|
26495840 |
2016 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
To characterize their effect on atherogenesis, APOE*3Leiden.CETP mice were fed a high cholesterol/high fat diet (WTD) or normal chow (NC) for 18 weeks.
|
31366894 |
2019 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Hypercholesterolemia-Induced Loss of Flow-Induced Vasodilation and Lesion Formation in Apolipoprotein E-Deficient Mice Critically Depend on Inwardly Rectifying K<sup>+</sup> Channels.
|
29502106 |
2018 |
Hypercholesterolemia
|
0.700 |
Biomarker
|
disease |
BEFREE |
The combination of APOE epsilon4 with hypercholesterolemia or diabetes showed the greatest cognitive decline.
|
15668424 |
2005 |